Wed, November 27, 2024
Tue, November 26, 2024
[ Tue, Nov 26th 2024 ] - Brian Stokes
Trust Matters in Cabinet Picks
Mon, November 25, 2024
Sun, November 24, 2024
Thu, November 14, 2024
Tue, November 12, 2024
Thu, April 23, 2009
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Nathan Burkes
Is Obama a rock star?
Fri, January 30, 2009

BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017


//health-fitness.news-articles.net/content/2017/ .. -and-provide-business-update-on-may-11-2017.html
Published in Health and Fitness on Thursday, May 4th 2017 at 3:44 GMT by Market Wire   Print publication without navigation


BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May

BOTHELL, Wash., May 4, 2017 /PRNewswire/ -- [ BioLife Solutions ], Inc. (NASDAQ: [ BLFS ]), a leading developer, manufacturer and marketer of proprietary clinical grade [ hypothermic storage ] and [ cryopreservation freeze ] media ("BioLife" or the "Company"), today announced that the Company's first quarter 2017 financial results will be released after market close on Thursday, May 11, 2017, and that the Company will host a conference call and live webcast at 1:30 p.m. PT that afternoon. Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log on to the Investor Relations page of the BioLife Solutions website at [ www.biolifesolutions.com ]. Alternatively, you may access the live conference call by dialing (844) 825-0512 (U.S. &Canada) or (315) 625-6880 (International) with the following Conference ID: 17308601. A webcast replay will be available approximately two hours after the call and will be archived on [ www.biolifesolutions.com ] for 90 days.

About BioLife Solutions

The Company's proprietary HypoThermosol and CryoStor platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

For more information please visit [ www.biolifesolutions.com ], and follow BioLife on [ Twitter ].

Media & Investor Relations

Roderick de Greef

Chief Financial Officer

(425) 402-1400

[ rdegreef@biolifesolutions.com ]

SOURCE BioLife Solutions, Inc.



RELATED LINKS

[ http://www.biolifesolutions.com ]



Publication Contributing Sources